We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$372M
AUM Growth
+$10.5M
Cap. Flow
+$3.66M
Cap. Flow %
0.99%
Top 10 Hldgs %
17.28%
Holding
264
New
49
Increased
26
Reduced
48
Closed
45

Top Buys

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$3.95M
2
GNRC icon
Generac Holdings
GNRC
+$3.69M
3
XYL icon
Xylem
XYL
+$3.63M
4
CHRW icon
C.H. Robinson
CHRW
+$3.57M
5
AMRX icon
Amneal Pharmaceuticals
AMRX
+$3.51M

Sector Composition

Rank Sector Weight
1 Healthcare 16.62%
2 Technology 16.03%
3 Consumer Discretionary 15.97%
4 Materials 12.67%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAFM
101
DELISTED
Sanderson Farms Inc
SAFM
$1.63M 0.44%
15,500
CHS
102
DELISTED
Chicos FAS, Inc.
CHS
$1.63M 0.44%
+200,000
New +$1.89M
DAR icon
103
Darling Ingredients
DAR
$9.64B
$1.61M 0.43%
81,000
-75,000
-48% -$1.36M
ATHN
104
DELISTED
Athenahealth, Inc.
ATHN
$1.59M 0.43%
+10,000
New +$1.48M
BJRI icon
105
BJ's Restaurants
BJRI
$1.42B
$1.59M 0.43%
26,500
+25,000
+1,667% +$1.34M
CSCO icon
106
Cisco
CSCO
$457B
$1.59M 0.43%
36,900
+35,000
+1,842% +$1.53M
LMNX
107
DELISTED
Luminex Corp
LMNX
$1.56M 0.42%
53,000
+50,000
+1,667% +$1.28M
FLO icon
108
Flowers Foods
FLO
$1.49B
$1.56M 0.42%
75,000
-75,000
-50% -$1.6M
AMCX icon
109
AMC Global Media
AMCX
$492M
$1.55M 0.42%
+25,000
New +$1.43M
IQV icon
110
IQVIA
IQV
$38.7B
$1.5M 0.4%
15,000
-15,000
-50% -$1.5M
EXAS
111
DELISTED
Exact Sciences
EXAS
$1.5M 0.4%
25,000
-50,000
-67% -$2.69M
FDS icon
112
Factset
FDS
$9.36B
$1.49M 0.4%
+7,500
New +$1.5M
WH icon
113
Wyndham Hotels & Resorts
WH
$5.56B
$1.47M 0.4%
+25,000
New +$1.54M
DATA
114
DELISTED
Tableau Software, Inc.
DATA
$1.47M 0.39%
+15,000
New +$1.38M
BIIB icon
115
Biogen
BIIB
$30B
$1.45M 0.39%
5,000
-5,000
-50% -$1.41M
BMY icon
116
Bristol-Myers Squibb
BMY
$133B
$1.38M 0.37%
25,000
M icon
117
Macy's
M
$6.53B
$1.38M 0.37%
+36,800
New +$1.23M
AAL icon
118
American Airlines Group
AAL
$10.1B
$1.33M 0.36%
35,000
-31,200
-47% -$1.38M
MLNX
119
DELISTED
Mellanox Technologies, Ltd.
MLNX
$1.26M 0.34%
15,000
ST icon
120
Sensata Technologies
ST
$6.74B
$1.25M 0.34%
26,200
+25,000
+2,083% +$1.3M
UNH icon
121
UnitedHealth
UNH
$376B
$1.23M 0.33%
5,000
-5,000
-50% -$1.2M
WBA
122
DELISTED
Walgreens Boots Alliance
WBA
$1.2M 0.32%
20,000
GTN icon
123
Gray Television
GTN
$415M
$1.19M 0.32%
75,000
-104,500
-58% -$1.25M
RRGB icon
124
Red Robin
RRGB
$145M
$1.17M 0.31%
25,000
-41,500
-62% -$2.35M
HIBB
125
DELISTED
Hibbett, Inc. Common Stock
HIBB
$1.15M 0.31%
+50,000
New +$1.3M

Similar funds

Hussman Strategic Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Hussman Strategic Advisors held 264 positions worth $372M, up 2.9% from $361M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hussman Strategic Advisors's Q2 2018 filing shows 49 new, 26 increased, 48 reduced and 45 closed positions. Its largest new stake was Fastenal: 304,800 shares worth $3.67M. The largest sale was Impax Laboratories, Inc., an estimated $3.89M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Hussman Strategic Advisors's largest Q2 2018 buy was Fastenal: 304,800 shares worth $3.67M.
  • Hussman Strategic Advisors added most to C.H. Robinson in Q2 2018, an estimated $3.57M increase.
  • Hussman Strategic Advisors's biggest Q2 2018 reduction was Varian Medical Systems, Inc., cutting an estimated $2.99M.
  • Hussman Strategic Advisors fully exited Impax Laboratories, Inc. in Q2 2018, selling an estimated $3.89M.
  • Hussman Strategic Advisors's ten largest holdings make up 17% of its $372M portfolio in Q2 2018.
  • Hussman Strategic Advisors opened 49 new positions and closed 45 in Q2 2018.
  • Hussman Strategic Advisors's portfolio value rose 2.9% quarter-over-quarter to $372M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2018, filed 31 Jul 2018.